Immune Signatures Identify Patient Subsets Deriving Long‐Term Benefit From First‐Line Rituximab in Follicular Lymphoma by Ginevra Lolli, Alessandro Davini, Valentina Tabanelli, Maria Rosaria Sapienza, Federica Melle, Giovanna Motta, Marcello Del Corvo, Angelica Calleri, Anna Vanazzi, Paulina Nierychlewska, Alessio Maria Edoardo Maraglino, Marta Castelli, Maria Chiara Quattrocchi, Roberto Chiarle, Stefano Pileri, Corrado Tarella, Enrico Derenzini

Get full text